Pfizer’s Marstacimab Wins In Phase III, But Caution On Market Position, Clotting Remain

 
• By Alaric DeArment
  
Pfizer announced Phase III results for marstacimab in hemophilia • Source: Shutterstock

More from Clinical Trials

More from R&D